Stocks › CMPS

COMPASS Pathways plc

CMPS·Nasdaq·United Kingdom United Kingdom·USD
$8.05
-0.60 (-6.94%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
CMPS
COMPASS Pathways plc · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CMPSS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of CMPS by members of U.S. Congress · 1 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Shri ThanedarShri ThanedarHouse · D · MI CMPSCOMPASS Pathways plc · Stock Sale
$1,001 - $15,000
Feb 9, 2023 Jan 23, 2023 Filing ↗

Whale Activity

Position changes in CMPS reported for 2026-09-30 by 276 institutional filers
Increased: 73New: 48Held: 48Decreased: 56Closed: 38No prior filing: 13
  • Increased73
  • New48
  • Held48
  • Decreased56
  • Closed38
  • No prior filing13
FilerSharesValueChange
Deep Track Capital, LP12.2M$151.3Mheld
RTW INVESTMENTS, LP10.9M$136.2Mincreased
BIT Capital GmbH9.0M$111.6Mincreased
TANG CAPITAL MANAGEMENT LLC5.2M$64.7Mincreased
ARK Investment Management LLC4.9M$61.0Mincreased
Point72 Asset Management, L.P.4.7M$58.9Mincreased
TWO SIGMA INVESTMENTS, LP4.3M$53.2Mdecreased
BANK OF AMERICA CORP /DE/3.2M$39.8Mincreased
UBS Group AG3.1M$38.8Mincreased
PRICE T ROWE ASSOCIATES INC /MD/2.3M$28.2Mnew
DAFNA Capital Management LLC2.1M$26.6Mincreased
Eagle Health Investments LP2.1M$25.6Mheld

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by CMPS insiders, by quarter · Form 4

No open-market insider buys or sells in the last two years.

Recent Insider Transactions

157 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Nath KabirChief Executive Officer · Director Tax withholding −5,962 $11.25 $67K Aug 3, 2026 Form 4 ↗
Nath KabirChief Executive Officer · Director Grant / award +175.0K $0.00 $0 Mar 26, 2026 Form 4 ↗
Loxam TeriChief Financial Officer Grant / award +75.0K $0.00 $0 Mar 26, 2026 Form 4 ↗
Nath KabirChief Executive Officer · Director Tax withholding −13.1K $6.89 $90K Mar 11, 2026 Form 4 ↗
Loxam TeriChief Financial Officer Tax withholding −1,781 $6.89 $12K Mar 11, 2026 Form 4 ↗
Loxam TeriChief Financial Officer Tax withholding −4,467 $7.02 $31K Mar 2, 2026 Form 4 ↗
Nath KabirChief Executive Officer · Director Tax withholding −16.2K $6.61 $107K Feb 2, 2026 Form 4 ↗
Nath KabirChief Executive Officer · Director Tax withholding −6,366 $4.34 $28K Aug 1, 2025 Form 4 ↗
Loxam TeriChief Financial Officer Grant / award +25.0K $0.00 $0 Mar 11, 2025 Form 4 ↗
Nath KabirChief Executive Officer · Director Grant / award +92.0K $0.00 $0 Mar 11, 2025 Form 4 ↗
Loxam TeriChief Financial Officer Tax withholding −4,468 $3.67 $16K Mar 3, 2025 Form 4 ↗
Nath KabirChief Executive Officer · Director Tax withholding −15.5K $4.31 $67K Feb 3, 2025 Form 4 ↗
Malievskaia Ekaterina10% owner Sale −776.6K — — Oct 24, 2024 Form 4 ↗
Malievskaia Ekaterina10% owner Sale −776.6K — — Oct 24, 2024 Form 4 ↗
Goldsmith George Jay10% owner Sale −776.6K — — Oct 24, 2024 Form 4 ↗
Goldsmith George Jay10% owner Sale −776.6K — — Oct 24, 2024 Form 4 ↗
ATAI Life Sciences AG10% owner Sale −2.7M n/c — Sep 26, 2024 Form 4 ↗
Jenkins AnnalisaDirector Tax withholding −161 $6.88 $1K Aug 1, 2024 Form 4 ↗
Nath KabirChief Executive Officer · Director Tax withholding −7,064 $6.88 $49K Aug 1, 2024 Form 4 ↗
Malievskaia Ekaterina10% owner Sale −8,900 $7.91 $70K May 21, 2024 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding CMPS · SEC Form N-PORT
FundSharesValue% of fundAs of
ARK Genomic Revolution ETF
ARK ETF Trust
4.5M$50.7M3.25%Jul 31, 2026
iShares Biotechnology ETF
iShares Trust
764.9K$10.8M0.12%Jun 30, 2026
AdvisorShares Psychedelics ETF
AdvisorShares Trust
359.6K$5.1M11.45%Jun 30, 2026
Columbia Small Cap Value Discovery Fund
COLUMBIA FUNDS SERIES TRUST I
420.9K$3.8M0.17%Apr 30, 2026
Royce Smaller-Companies Growth Fund
ROYCE FUND
178.0K$2.5M1.06%Jun 30, 2026
ALPS Medical Breakthroughs ETF
ALPS ETF TRUST
166.5K$2.2M0.94%Aug 31, 2026
Goldman Sachs Small Cap Growth Fund
Goldman Sachs Trust
152.3K$2.1M0.44%Aug 31, 2026
Simplify Propel Opportunities ETF
Simplify Exchange Traded Funds
114.3K$1.6M2.09%Jun 30, 2026
Adara Smaller Companies Fund
RBB Fund, Inc.
113.4K$1.5M0.18%Aug 31, 2026
ROYCE SMALL-CAP TRUST, INC.89.0K$1.3M0.05%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list CMPS's shares (CUSIP 20451W101), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • BIT Capital GmbHSCHEDULE 13G · passive (13G) · 8.1M shares5.9%
    Oct 28, 2026 · ↗
  • Roderick WongSCHEDULE 13G/A · passive (13G) · 13.0M shares9.9%
    May 15, 2026 · ↗
  • RTW Investments, LPSCHEDULE 13G/A · passive (13G) · 13.0M shares9.9%
    May 15, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming compass pathways as client
$0$250K$500K$750K$1.0M2024 Q1: $60K2024 Q2: $60K2024 Q3: $60K2024 Q4: $60K20242025 Q1: $60K2025 Q2: $60K2025 Q3: $300K2025 Q4: $180K20252026 Q1: $190K2026 Q2: $240K2026 Q3: $370K2026
  • AVENUE SOLUTIONSCOMPASS PATHWAYS, INC. · 2026 Q3 · HCR$80K
    Filing ↗
  • COMPASS PATHWAYS INC.COMPASS PATHWAYS INC. · 2026 Q3 · BUD$210K
    Filing ↗
  • TODD STRATEGY GROUPCOMPASS PATHWAYS INC. · 2026 Q3 · HCR$80K
    Filing ↗
  • TODD STRATEGY GROUPCOMPASS PATHWAYS INC. · 2026 Q2 · HCR$80K
    Filing ↗
  • AVENUE SOLUTIONSCOMPASS PATHWAYS, INC. · 2026 Q2 · HCR$30K
    Filing ↗

Government Contracts

Federal awards to COMPASS Pathways plc · USAspending

No federal contract awards found for COMPASS Pathways plc.

U.S. Patents

Recent USPTO applications naming COMPASS Pathways plc

No USPTO patent applications found for COMPASS Pathways plc.

Annual Financials

From CMPS's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Operating income-$179.0M-$178.2M-$136.9M-$110.4M-$83.2M
Net income-$287.9M-$155.1M-$118.5M-$91.5M-$71.7M
Diluted EPS-$3.08-$2.30-$2.32-$2.16-$1.79
Operating cash flow-$157.2M-$119.2M-$97.4M-$105.5M-$67.7M
Cash and equivalents$149.6M$165.1M$220.2M$143.2M$273.2M
Total assets$210.3M$213.7M$276.0M$197.3M$300.9M
Total liabilities$263.2M$59.0M$50.2M$16.0M$16.5M
Shareholders' equity-$52.8M$154.7M$225.7M$181.3M$284.4M

As COMPASS Pathways plc tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Mar 24, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in CMPS's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsNov 3, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 5, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsJul 7, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteMay 28, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 13, 2026
    EDGAR ↗

About COMPASS Pathways plc

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersCHESIRE, United Kingdom
IncorporatedX0
Former namesCompass Rx Ltd.